Yongin-si, South Korea

Suk Man Jang



Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suk Man Jang: Innovator in Pharmaceutical Chemistry

Introduction

Suk Man Jang is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for preparing important compounds used in medical treatments.

Latest Patents

One of Suk Man Jang's key patents is titled "Method for preparation of Montelukast acid in ionic liquid medium." This invention relates to a method for preparing Montelukast acid or its sodium salt by reacting a thiol compound with a Montelukast intermediate in the presence of a base in a medium comprising an ionic liquid compound. The method allows for the easy preparation of highly pure Montelukast acid or its sodium salt, which is beneficial as a raw material in the preparation of Montelukast, a leukotriene antagonist. This innovation is significant due to its high yield and purity.

Career Highlights

Suk Man Jang is currently associated with Hanmi Science Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in chemical processes and formulations has positioned him as a valuable asset in his field.

Collaborations

Suk Man Jang has collaborated with notable colleagues, including Chul-Hyun Park and Eun-Ju Park. Their combined efforts contribute to advancements in pharmaceutical research and development.

Conclusion

Suk Man Jang's work exemplifies the importance of innovation in the pharmaceutical industry. His contributions, particularly in the preparation of Montelukast acid, highlight the potential for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…